Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.

@article{Ersbll2014TreatmentWO,
  title={Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.},
  author={Anne Schj\odt Ersb\oll and Mette Hedegaard and L. G. S\ondergaard and Mads Kristian Ersb\oll and Marianne Johansen},
  journal={BJOG : an international journal of obstetrics and gynaecology},
  year={2014},
  volume={121 5},
  pages={618-26}
}
OBJECTIVE To investigate the effect on fetal growth of treatment with oral beta-blockers during pregnancy in women with congenital or acquired heart disease. DESIGN Historical matched cohort study. SETTING Centre for Pregnant Women with Heart Disease, Copenhagen University Hospital, Denmark. POPULATION A cohort of 175 women with heart disease, grouped according to beta-blocker treatment, and a cohort of 627 women from the overall population matched on seven birthweight-determining factors… CONTINUE READING